Machine learning model could accelerate drug discovery

Researchers from the University of Warwick in the United Kingdom have developed a machine learning model capable of predicting the interactions between proteins and drug molecules with 99 percent accuracy. Findings have been published in Science Advances.

The algorithm aims to accelerate drug discovery by using only a handful of reference experiments to provide accurate results determining whether a drug molecule will bind to a target protein. Additionally, the model is able to provide insight into intermolecular forces by outlining solutions to material-science problems like modeling to silicon surfaces.

"This work is exciting because it provides a general-purpose machine learning approach that is applicable both to materials and molecules,” said James Kermode, from the University of Warwick's Center for Predictive Modeling. "The research is expected to lead to a significant increase in the accuracy and transferability of models used for drug design and to describe the mechanical properties of materials."

Researchers developed the algorithm by combining local information of each atom in a structure and makes it applicable on different classes of chemical, material science and biochemical problems. This design makes the machine learning model able to predict the stability of organic molecules and the energy balance in silicone structures for microelectronic applications.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”